Synchron
3 employees
Biotech
Series D · $345.0M
Open positions (15)
Company details
Team Size3
IndustryBiotech
Funding
Total raised
$345.0M
Last stage
Series D
Investors
Total raised
$345.0M
Last stage
Series D
Investors
Thomas Oxley
Australian-born physician, neuroscientist, and entrepreneur. Founder and CEO of Synchron. His PhD work began in 2012 and he moved to the US in 2015. Also founded SmartStent (acquired by Synchron) and VascuLab.
LinkedInNicholas Opie
Co-founder and Chief Technology Officer at Synchron, focused on the engineering of the Stentrode endovascular brain-computer interface.
Rahul Sharma
Co-founder and Medical Director at Synchron, listed on the company's official About Us page.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.